NCT05129215

Brief Summary

Bowel dysfunction is common after a restorative rectal cancer resection. Neoadjuvant radiotherapy is an influential factor that impairs bowel function and quality of life. However, almost half patients who have received primary surgery with preoperative radiotherapy are able to restore a good or moderate bowel function in the long term. This multicenter observational study aims to identify the risk factors of severe bowel dysfunction after rectal cancer resection and neoadjuvant radiotherapy, in accordance with the LARS score, and to build a model that predicts long-term major LARS in the early stage of follow-up. Development and validation cohorts are enrolled from tertiary hospitals in China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
901

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

2.7 years

First QC Date

November 15, 2021

Last Update Submit

November 25, 2022

Conditions

Keywords

Bowel DysfunctionLow Anterior Resection SyndromeRadiotherapyRectal Cancer

Outcome Measures

Primary Outcomes (1)

  • Area under the curve (AUC)

    The AUC of PORTLARS in predicting major bowel dysfunction after restorative rectal cancer resection with neoadjuvant radiotherapy. The AUC is evaluated by calculating the area under curve of receiver operating characteristics which plots the proportion of true positive cases (sensitivity) against the proportion of false positive cases (1-specificity) based on various predictive probability threshold.

    Over one year after restorative rectal cancer resection

Secondary Outcomes (4)

  • Sensitivity

    Over one year after restorative rectal cancer resection

  • Specificity

    Over one year after restorative rectal cancer resection

  • Positive prediction value (PPV)

    Over one year after restorative rectal cancer resection

  • Negative prediction value (NPV)

    Over one year after restorative rectal cancer resection

Other Outcomes (1)

  • Net reclassification index (NRI)

    Over one year after restorative rectal cancer resection

Study Arms (3)

Development

A primary cohort of eligible patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for model derivation.

Other: Questionnaire

Internal cross-validation

A cohort of consecutive patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for internal cross-validation.

Other: Questionnaire

External validation

An independent cohort of eligible patients from other hospitals is used for external validation.

Other: Questionnaire

Interventions

The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.

DevelopmentExternal validationInternal cross-validation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who underwent preoperative radiotherapy and curative low anterior resection for nonmetastatic rectal cancer.

You may qualify if:

  • Curative low anterior resection for nonmetastatic rectal cancer
  • Preoperative radiotherapy

You may not qualify if:

  • Death
  • Metastasis or recurrence
  • Postoperative radiotherapy
  • Cognitive disorder
  • Intestinal stoma
  • Rectal cancer resection for \<12 months
  • Stoma reversal for \<6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sixth Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

Related Publications (1)

  • Qin Q, Huang B, Wu A, Gao J, Liu X, Cao W, Ma T, Kuang Y, Guo J, Wu Q, Shao B, Guan Q, Yao H, Zhang X, Wang H; Chinese Radiation Intestinal Injury Research Group. Development and Validation of a Post-Radiotherapy Prediction Model for Bowel Dysfunction After Rectal Cancer Resection. Gastroenterology. 2023 Dec;165(6):1430-1442.e14. doi: 10.1053/j.gastro.2023.08.022. Epub 2023 Aug 23.

MeSH Terms

Conditions

Low Anterior Resection SyndromeRectal NeoplasmsIntestinal Diseases

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Colonic DiseasesGastrointestinal DiseasesDigestive System DiseasesRectal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Qiyuan Qin, M.D.

    Sixth Affiliated Hospital, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2021

First Posted

November 22, 2021

Study Start

March 6, 2020

Primary Completion

October 31, 2022

Study Completion

October 31, 2022

Last Updated

November 30, 2022

Record last verified: 2022-11

Locations